Jill Broadfoot, CFO, aTyr Pharma
Jill Broadfoot serves as aTyr Pharma’s Chief Financial Officer. Prior to aTyr, Ms. Broadfoot was CFO at both Emerald Health Pharmaceuticals and Emerald Health Bioceuticals where she established operations in their related cannabis industries. She was VP, U.S. Corporate Controller at GW Pharmaceuticals where she helped establish U.S. commercial and corporate operations. She also served as CFO of Vical where she had oversight of finance, manufacturing, IR, HR and BD. Ms. Broadfoot held various positions at DJO Global and Ernst & Young. Ms. Broadfoot graduated from SDSU and is a CPA.